0002108304-26-000001.txt : 20260203 0002108304-26-000001.hdr.sgml : 20260203 20260203123315 ACCESSION NUMBER: 0002108304-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20260203 DATE AS OF CHANGE: 20260203 EFFECTIVENESS DATE: 20260203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Blackwing Embryo Jan 2026 a Series of CGF2021 LLC CENTRAL INDEX KEY: 0002108304 ORGANIZATION NAME: EIN: 413575085 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-572217 FILM NUMBER: 26591299 BUSINESS ADDRESS: STREET 1: 2093 PHILADELPHIA PIKE STREET 2: 5885 CITY: CLAYMONT STATE: DE ZIP: 19703 BUSINESS PHONE: (360) 946-0604 MAIL ADDRESS: STREET 1: 2093 PHILADELPHIA PIKE STREET 2: 5885 CITY: CLAYMONT STATE: DE ZIP: 19703 D 1 primary_doc.xml X0708 D LIVE 0002108304 Blackwing Embryo Jan 2026 a Series of CGF2021 LLC 2093 PHILADELPHIA PIKE 5885 CLAYMONT DE DELAWARE 19703 (360) 946-0604 DELAWARE None None Limited Liability Company true 2026 LLC Sydecar 2093 Philadelphia Pike #5885 Claymont DE DELAWARE 19703 Director Administrator of the Issuer Brett Sagan c/o Sydecar LLC 2093 Philadelphia Pike #5885 Claymont DE DELAWARE 19703 Executive Officer Officer of the Issuer's Administrator Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 false 2026-02-02 false true false 0 85000 85000 0 false 6 0 0 4500 This amount represents a cost to cover fund organizational and operating expenses false Blackwing Embryo Jan 2026 a Series of CGF2021 LLC /s/ Brett Sagan Brett Sagan General Manager of Sydecar LLC, a Manager of the Applicant 2026-02-03